Materials and methods for improving efficacy of adoptive immune cell therapy
AssigneeMayo Foundation for Medical Education and Research
InventorsJoerg J. Goronzy, Cornelia M. Weyand, Jun Jin
Life of this patent
Estimating the term…
Abstract
Methods and materials for treating cancer (e.g., melanoma) in a subject and for improving efficacy of adoptive immune cell therapy are described. The methods can include administering immune cells (e.g., chimeric antigen receptor T cells or tumor-infiltrating lymphocytes) having reduced expression of a VPS39 polypeptide to the subject.
Claims15
A method for treating cancer in a subject, said method comprising administering, to said subject, engineered immune cells, wherein said immune cells have reduced expression of a VPS39 polypeptide.
A method of increasing efficacy of adoptive cell transfer in a subject, said method comprising administering to the subject chimeric antigen receptor T cells having reduced expression of a VPS39 polypeptide.
An immune cell comprising an inactivated VPS39 gene.
An isolated immune cell comprising a disrupted nucleic acid encoding a VPS39 polypeptide, wherein said cell does not express an endogenous VPS39 polypeptide.
Dependencies are inferred from the claim text.